Kirk Reed
Optometrist · Queen Creek, AZNPI 1497735294
Payments from drug & device makers
Across 39 payments — averaging $20.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$298
- Johnson & Johnson Vision Care, Inc.$119
- Bausch & Lomb Americas Inc.$109
- Tarsus Pharmaceuticals, Inc.$64
- Kala Pharmaceuticals, Inc.$37
- Bausch & Lomb, A Division Of Bausch Health US, LLC$31
- plus $141 from 7 others
What the payments were for
- Food & beverage$78798%
- Entertainment$132%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 13 | $298 |
| Johnson & Johnson Vision Care, Inc. | 7 | $119 |
| Bausch & Lomb Americas Inc. | 5 | $109 |
| Tarsus Pharmaceuticals, Inc. | 2 | $64 |
| Kala Pharmaceuticals, Inc. | 2 | $37 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $31 |
| AbbVie(2 entities) | 2 | $29 |
| Coopervision Inc. | 1 | $27 |
| Oyster Point Pharma, Inc. | 1 | $23 |
| Novartis | 1 | $20 |
| Visioneering Technologies, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Optos, Inc. | 1 | $13 |
How this compares
$800 in reported general payments places this provider in the 45th percentile of 1,134 optometrist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 13 | $132 |
| Latanoprost | 13 | $83 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Queen Creek
- Marc BloomensteinScottsdale$2.3M
- Stephanie WooLake Havasu City$540K
- Kevin HelmuthSacaton$281K
- Christina SorensonGlendale$181K
- Jashpal RajasansiGilbert$120K
- Michelle Marie MijaresFort Defiance$38K
- Jamie KuhnGlendale$37K
- Tania SobchukLake Havasu City$32K
- Stephen CohenScottsdale$32K
- Florencia YehGlendale$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.